127 related articles for article (PubMed ID: 32258333)
1. Dedifferentiated endometrioid adenocarcinoma with trophoblastic components: Prolonged remission after treatment with bleomycin, etoposide, and cisplatin.
Martin AK; Jackson EG; Edwards HD; Stany MP
Gynecol Oncol Rep; 2020 May; 32():100562. PubMed ID: 32258333
[TBL] [Abstract][Full Text] [Related]
2. Dedifferentiated endometrioid adenocarcinoma with trophoblastic components and elevated serum alfa-fetoprotein: A case report and literature review.
Cai H; Zhou R; Liang W; Wang J
Medicine (Baltimore); 2018 Apr; 97(17):e0551. PubMed ID: 29703038
[TBL] [Abstract][Full Text] [Related]
3. Dedifferentiated endometrioid adenocarcinoma of the uterus: A case series and review of literature.
Goh C; Farah BL; Ho WY; Wong SL; Goh CHR; Chew SH; Nadarajah R; Lim YK; Ho TH
Gynecol Oncol Rep; 2020 May; 32():100538. PubMed ID: 32090165
[TBL] [Abstract][Full Text] [Related]
4. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
Song SQ; Zhang GN
Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
[TBL] [Abstract][Full Text] [Related]
5. Dedifferentiated endometrioid adenocarcinoma of the uterus: a case report.
Soyama H; Takano M; Miyamoto M; Kato M; Goto T; Furuya K
Eur J Gynaecol Oncol; 2016; 37(3):426-9. PubMed ID: 27352580
[TBL] [Abstract][Full Text] [Related]
6. Endometrial Carcinoma With Trophoblastic Components: Clinicopathologic Analysis of a Rare Entity.
Rawish KR; Buza N; Zheng W; Fadare O
Int J Gynecol Pathol; 2018 Mar; 37(2):174-190. PubMed ID: 28582346
[TBL] [Abstract][Full Text] [Related]
7. Placental site trophoblastic tumor: a review of 7 cases and their implications for prognosis and treatment.
Hoekstra AV; Keh P; Lurain JR
J Reprod Med; 2004 Jun; 49(6):447-52. PubMed ID: 15283052
[TBL] [Abstract][Full Text] [Related]
8. Endometrial adenocarcinoma with trophoblastic differentiation.
Bradley CS; Benjamin I; Wheeler JE; Rubin SC
Gynecol Oncol; 1998 Apr; 69(1):74-7. PubMed ID: 9571002
[TBL] [Abstract][Full Text] [Related]
9. Dedifferentiated endometrioid adenocarcinoma; clinicopathologic and immunohistochemical features of five cases.
Yiğit S; Ekinci N; Hayrullah L; Öcal İ; Bezircioğlu İ
J Turk Ger Gynecol Assoc; 2018 Aug; 19(3):132-136. PubMed ID: 29545232
[TBL] [Abstract][Full Text] [Related]
10. EP-EMA regimen (etoposide and cisplatin with etoposide, methotrexate, and dactinomycin) in a series of 18 women with gestational trophoblastic neoplasia.
Han SN; Amant F; Leunen K; Devi UK; Neven P; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):875-80. PubMed ID: 22635033
[TBL] [Abstract][Full Text] [Related]
11. Dedifferentiated endometrioid carcinoma of the uterus : report of four cases and review of literature.
Han J; Ki EY; Rha SE; Hur S; Lee A
World J Surg Oncol; 2017 Jan; 15(1):17. PubMed ID: 28069049
[TBL] [Abstract][Full Text] [Related]
12. Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors.
Newlands ES; Mulholland PJ; Holden L; Seckl MJ; Rustin GJ
J Clin Oncol; 2000 Feb; 18(4):854-9. PubMed ID: 10673528
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of a phase III study of three versus four cycles of bleomycin, etoposide, and cisplatin in favorable-prognosis germ-cell tumors: the Indian University experience.
Saxman SB; Finch D; Gonin R; Einhorn LH
J Clin Oncol; 1998 Feb; 16(2):702-6. PubMed ID: 9469360
[TBL] [Abstract][Full Text] [Related]
14. High dose chemotherapy with ifosfamide, carboplatin, and etoposide combined with autologous bone marrow transplantation for the treatment of poor-prognosis germ cell tumors and metastatic trophoblastic disease in adults.
Lotz JP; André T; Donsimoni R; Firmin C; Bouleuc C; Bonnak H; Merad Z; Esteso A; Gerota J; Izrael V
Cancer; 1995 Feb; 75(3):874-85. PubMed ID: 7828139
[TBL] [Abstract][Full Text] [Related]
15. Risk-adapted chemotherapy of germ cell tumors with carboplatin, etoposide and bleomycin for low-risk and cisplatin, etoposide and ifosfamide for high-risk patients. A single-center study.
Tscherry G; Jacky E; Jost LM; Stahel RA
Oncology; 2000 Aug; 59(2):110-7. PubMed ID: 10971168
[TBL] [Abstract][Full Text] [Related]
16. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
Lurain JR; Nejad B
Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
[TBL] [Abstract][Full Text] [Related]
17. Poor-prognosis gestational trophoblastic disease: an update.
Surwit EA; Alberts DS; Christian CD; Graham VE
Obstet Gynecol; 1984 Jul; 64(1):21-6. PubMed ID: 6204257
[TBL] [Abstract][Full Text] [Related]
18. Etoposide-platin combination therapy for chemorefractory gestational trophoblastic disease.
Soper JT; Evans AC; Rodriguez G; Berchuck A; Clarke-Pearson DL; Hammond CB
Gynecol Oncol; 1995 Mar; 56(3):421-4. PubMed ID: 7705678
[TBL] [Abstract][Full Text] [Related]
19. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
Motzer RJ; Mazumdar M; Gulati SC; Bajorin DF; Lyn P; Vlamis V; Bosl GJ
J Natl Cancer Inst; 1993 Nov; 85(22):1828-35. PubMed ID: 7693955
[TBL] [Abstract][Full Text] [Related]
20. A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors.
Bokemeyer C; Köhrmann O; Tischler J; Weissbach L; Räth U; Haupt A; Schöffski P; Harstrick A; Schmoll HJ
Ann Oncol; 1996 Dec; 7(10):1015-21. PubMed ID: 9037359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
